Symbols / NMTC Stock $4.85 -5.10% NeuroOne Medical Technologies Corporation

Healthcare • Medical Devices • United States • NCM
NMTC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Stock Fundamentals
Scroll to Statements
Market Cap 40.97M Enterprise Value 39.71M Income -6.83M Sales 11.72M Book/sh 0.76 Cash/sh 0.42
Dividend Yield — Payout 0.00% Employees 18 IPO — P/E — Forward P/E -17.32
PEG — P/S 3.50 P/B 6.36 P/C — EV/EBITDA -5.38 EV/Sales 3.39
Quick Ratio 4.95 Current Ratio 6.41 Debt/Eq 3.71 LT Debt/Eq — EPS (ttm) -1.08 EPS next Y -0.28
EPS Growth — Revenue Growth -11.70% Earnings 2026-05-12 ROA -63.40% ROE -146.27% ROIC —
Gross Margin 22.03% Oper. Margin -59.02% Profit Margin -58.28% Shs Outstand 8.45M Shs Float 7.75M Short Float 0.24%
Short Ratio 0.63 Short Interest — 52W High 6.96 52W Low 3.28 Beta 0.58 Avg Volume 41.05K
Volume 27.47K Target Price $12.20 Recom None Prev Close $5.11 Price $4.85 Change -5.10%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$12.20
Mean price target
2. Current target
$4.85
Latest analyst target
3. DCF / Fair value
$-8.35
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.85
Low
$9.00
High
$18.00
Mean
$12.20

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-02 init Jones Trading — → Buy $2
2025-09-09 init Maxim Group — → Buy $3
2025-05-05 init Ladenburg Thalmann — → Buy $1
2023-08-15 main Alliance Global Partners Buy → Buy $2
2022-03-28 down Craig-Hallum Buy → Hold —
2021-12-03 init Alliance Global Partners — → Buy $6
2021-11-15 init Craig-Hallum — → Buy $6
News
RSS: Latest NMTC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2020-06-15 MATHIESEN JEFFREY S Director — 34,020 $0.04 $1,191
2020-06-12 CHRISTIANSON MARK Officer — 334,000 $1.57 $524,380
2020-06-02 MATHIESEN JEFFREY S Director — 22,371 $0.00 $0
2020-06-02 BUCKMAN PAUL R Director — 22,371 $0.00 $0
2020-06-02 ANDRLE EDWARD Director — 22,371 $0.00 $0
2020-02-19 ANDRLE EDWARD Director — 7,064 $0.00 $0
2020-02-10 MATHIESEN JEFFREY S Director — 26,261 $0.00 $0
2020-02-10 BUCKMAN PAUL R Director — 44,118 $0.00 $0
2019-06-04 MATHIESEN JEFFREY S Director — 14,006 $0.00 $0
2019-06-04 BUCKMAN PAUL R Director — 14,006 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
9.10
+163.47%
3.45
+76.86%
1.95
+1040.65%
0.17
Operating Revenue
9.10
+163.47%
3.45
+76.86%
1.95
+1040.65%
0.17
Cost Of Revenue
3.96
+66.70%
2.37
+58.65%
1.50
+518.24%
0.24
Reconciled Cost Of Revenue
3.96
+66.70%
2.37
+58.65%
1.50
+518.24%
0.24
Gross Profit
5.14
+376.20%
1.08
+136.50%
0.46
+744.85%
-0.07
Operating Expense
9.37
-27.76%
12.97
+4.47%
12.41
+24.62%
9.96
Research And Development
4.98
-1.62%
5.07
-27.02%
6.94
+40.80%
4.93
Selling General And Administration
7.38
-6.55%
7.90
+14.08%
6.93
-0.76%
6.98
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Other Operating Expenses
-3.00
—
-1.46
+25.33%
-1.95
Total Expenses
13.32
-13.14%
15.34
+10.30%
13.91
+36.32%
10.20
Operating Income
-4.23
+64.45%
-11.89
+0.57%
-11.96
-19.19%
-10.03
Total Operating Income As Reported
-4.23
+64.45%
-11.89
+0.57%
-11.96
-19.19%
-10.03
EBITDA
-3.01
+74.59%
-11.84
-1.56%
-11.66
-17.64%
-9.91
Normalized EBITDA
-3.79
+67.05%
-11.52
+1.24%
-11.66
-17.64%
-9.91
Reconciled Depreciation
0.26
+6.03%
0.25
+23.85%
0.20
+67.99%
0.12
EBIT
-3.27
+72.94%
-12.09
-1.94%
-11.86
-18.23%
-10.03
Total Unusual Items
0.78
+339.89%
-0.33
—
—
Total Unusual Items Excluding Goodwill
0.78
+339.89%
-0.33
—
—
Special Income Charges
—
—
—
—
Net Income
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Pretax Income
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Non Operating Interest Income Expense
-0.33
-45.89%
-0.23
0.00
0.00
Interest Expense Non Operating
0.33
+45.89%
0.23
0.00
0.00
Net Interest Income
-0.33
-45.89%
-0.23
0.00
0.00
Interest Expense
0.33
+45.89%
0.23
0.00
0.00
Other Income Expense
0.96
+573.06%
-0.20
-310.86%
0.10
+207.39%
0.03
Other Non Operating Income Expenses
0.17
+36.20%
0.13
+30.72%
0.10
+207.39%
0.03
Gain On Sale Of Security
0.78
+339.89%
-0.33
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Income From Continuing Operation Net Minority Interest
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Income From Continuing And Discontinued Operation
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Income Continuous Operations
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Normalized Income
-4.39
+63.39%
-11.99
-1.11%
-11.86
-18.60%
-10.00
Net Income Common Stockholders
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Diluted EPS
-0.09
+80.43%
-0.46
+29.23%
-0.65
-3.17%
-0.63
Basic EPS
-0.09
+80.43%
-0.46
+29.23%
-0.65
-3.17%
-0.63
Basic Average Shares
40.15
+50.03%
26.76
+47.69%
18.12
+13.27%
16.00
Diluted Average Shares
40.15
+50.03%
26.76
+47.69%
18.12
+13.27%
16.00
Diluted NI Availto Com Stockholders
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
10.79
+100.85%
5.37
-33.68%
8.10
-36.85%
12.82
Current Assets
10.23
+120.83%
4.63
-36.67%
7.31
-39.94%
12.18
Cash Cash Equivalents And Short Term Investments
6.57
+350.01%
1.46
-72.57%
5.32
-52.23%
11.14
Cash And Cash Equivalents
6.57
+350.01%
1.46
-72.57%
5.32
-34.78%
8.16
Cash Financial
—
—
—
—
Other Short Term Investments
—
—
0.00
-100.00%
2.98
Receivables
1.26
+616.05%
0.18
0.00
-100.00%
0.03
Accounts Receivable
1.26
+616.05%
0.18
0.00
-100.00%
0.03
Inventory
2.23
-15.50%
2.64
+52.61%
1.73
+145.08%
0.70
Work In Process
0.13
-32.37%
0.19
-44.02%
0.34
+49.06%
0.23
Finished Goods
1.23
-21.75%
1.57
+768.35%
0.18
+143.77%
0.07
Prepaid Assets
0.14
-34.69%
0.22
-17.93%
0.26
-11.09%
0.30
Current Deferred Assets
0.02
-83.93%
0.14
0.00
0.00
Total Non Current Assets
0.56
-24.31%
0.74
-5.78%
0.78
+21.26%
0.65
Net PPE
0.51
-23.42%
0.67
-3.32%
0.69
+29.88%
0.53
Gross PPE
1.31
+6.66%
1.23
+19.56%
1.03
+42.77%
0.72
Accumulated Depreciation
-0.80
-42.78%
-0.56
-67.01%
-0.33
-79.75%
-0.19
Machinery Furniture Equipment
1.06
+8.37%
0.98
+13.43%
0.86
+45321.48%
0.00
Other Properties
0.26
+0.11%
0.25
+50.78%
0.17
-76.50%
0.72
Goodwill And Other Intangible Assets
0.04
-33.18%
0.07
-24.91%
0.09
-19.94%
0.11
Total Liabilities Net Minority Interest
3.71
-18.36%
4.55
+146.11%
1.85
-42.58%
3.22
Current Liabilities
2.30
+4.06%
2.21
+23.46%
1.79
-42.15%
3.10
Payables And Accrued Expenses
2.18
+4.33%
2.09
+25.49%
1.66
+6.62%
1.56
Payables
1.01
-1.83%
1.03
+50.23%
0.69
-26.15%
0.93
Accounts Payable
1.01
-1.83%
1.03
+50.23%
0.69
-26.15%
0.93
Current Accrued Expenses
1.17
+10.33%
1.06
+8.17%
0.98
+54.69%
0.63
Current Debt And Capital Lease Obligation
0.12
+88.02%
0.07
-49.06%
0.13
+54.93%
0.08
Current Capital Lease Obligation
0.12
+88.02%
0.07
-49.06%
0.13
+54.93%
0.08
Current Deferred Liabilities
—
—
0.00
-100.00%
1.46
Current Deferred Revenue
—
—
0.00
-100.00%
1.46
Other Current Liabilities
0.00
-97.61%
0.06
—
—
Total Non Current Liabilities Net Minority Interest
1.41
-39.61%
2.33
+4123.12%
0.06
-53.76%
0.12
Long Term Debt And Capital Lease Obligation
0.14
-26.36%
0.19
+251.62%
0.06
-53.76%
0.12
Long Term Capital Lease Obligation
0.14
-26.36%
0.19
+251.62%
0.06
-53.76%
0.12
Stockholders Equity
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Common Stock Equity
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Capital Stock
0.05
+62.27%
0.03
+28.78%
0.02
+47.56%
0.02
Common Stock
0.05
+62.27%
0.03
+28.78%
0.02
+47.56%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
50.01
+62.27%
30.82
+28.78%
23.93
+47.56%
16.22
Ordinary Shares Number
50.01
+62.27%
30.82
+28.78%
23.93
+47.56%
16.22
Additional Paid In Capital
85.63
+12.98%
75.80
+9.99%
68.91
+14.06%
60.41
Retained Earnings
-78.61
-4.81%
-75.00
-19.65%
-62.69
-23.33%
-50.83
Total Equity Gross Minority Interest
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Total Capitalization
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Working Capital
7.92
+227.72%
2.42
-56.20%
5.52
-39.18%
9.08
Invested Capital
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Total Debt
0.27
+2.55%
0.26
+41.08%
0.18
-9.12%
0.20
Capital Lease Obligations
0.27
+2.55%
0.26
+41.08%
0.18
-9.12%
0.20
Net Tangible Assets
7.03
+831.11%
0.75
-87.75%
6.16
-35.11%
9.49
Tangible Book Value
7.03
+831.11%
0.75
-87.75%
6.16
-35.11%
9.49
Derivative Product Liabilities
1.27
-40.81%
2.14
0.00
—
Other Inventories
0.87
-0.64%
0.88
-27.08%
1.20
+200.65%
0.40
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-2.84
+74.23%
-11.01
+14.55%
-12.89
-71.38%
-7.52
Cash Flow From Continuing Operating Activities
-2.84
+74.23%
-11.01
+14.55%
-12.89
-71.38%
-7.52
Net Income From Continuing Operations
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Depreciation Amortization Depletion
0.26
+6.03%
0.25
+23.85%
0.20
+67.99%
0.12
Depreciation
0.24
+6.63%
0.22
+26.86%
0.18
+83.74%
0.10
Amortization Cash Flow
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Depreciation And Amortization
0.26
+6.03%
0.25
+23.85%
0.20
+67.99%
0.12
Amortization Of Intangibles
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Other Non Cash Items
-0.34
-150.63%
0.67
+509.67%
0.11
-48.23%
0.21
Stock Based Compensation
1.26
-5.94%
1.34
+21.62%
1.11
+16.71%
0.95
Provisionand Write Offof Assets
0.01
0.00
—
—
Operating Gains Losses
—
—
0.03
—
Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.03
0.00
Change In Working Capital
-0.43
+55.04%
-0.95
+60.69%
-2.43
-300.11%
1.21
Change In Receivables
-1.09
-516.05%
-0.18
-631.44%
0.03
+120.13%
0.02
Changes In Account Receivables
-1.09
-516.05%
-0.18
-631.44%
0.03
+120.13%
0.02
Change In Inventory
0.40
+143.85%
-0.91
+11.12%
-1.02
-68.60%
-0.61
Change In Prepaid Assets
0.08
+58.80%
0.05
+43.71%
0.03
+122.61%
-0.15
Change In Payables And Accrued Expense
0.19
+122.99%
0.08
+105.65%
-1.47
-175.50%
1.95
Change In Accrued Expense
-0.05
-435.77%
0.02
+101.32%
-1.23
-185.40%
1.43
Change In Payable
0.24
+258.22%
0.07
+127.10%
-0.25
-147.96%
0.52
Change In Account Payable
0.24
+258.22%
0.07
+127.10%
-0.25
-147.96%
0.52
Investing Cash Flow
-0.08
+31.99%
-0.12
-104.54%
2.65
+181.67%
-3.24
Cash Flow From Continuing Investing Activities
-0.08
+31.99%
-0.12
-104.54%
2.65
+181.67%
-3.24
Net PPE Purchase And Sale
-0.08
+31.99%
-0.12
+68.09%
-0.38
-36.84%
-0.28
Purchase Of PPE
-0.08
+31.99%
-0.12
+68.71%
-0.38
-39.56%
-0.28
Sale Of PPE
—
0.00
-100.00%
0.01
0.00
Capital Expenditure
-0.08
+31.99%
-0.12
+68.71%
-0.38
-39.56%
-0.28
Net Investment Purchase And Sale
—
0.00
-100.00%
3.03
+201.92%
-2.97
Purchase Of Investment
—
0.00
+100.00%
-1.47
+57.53%
-3.47
Sale Of Investment
—
0.00
-100.00%
4.50
+800.00%
0.50
Financing Cash Flow
8.03
+10.45%
7.27
-1.75%
7.40
-38.46%
12.02
Cash Flow From Continuing Financing Activities
8.03
+10.45%
7.27
-1.75%
7.40
-38.46%
12.02
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
9.49
+63.91%
5.79
-31.66%
8.47
-36.55%
13.35
Common Stock Payments
-0.12
-53.09%
-0.08
+31.83%
-0.12
0.00
Repurchase Of Capital Stock
-0.12
-53.09%
-0.08
+31.83%
-0.12
0.00
Proceeds From Stock Option Exercised
0.07
-96.15%
1.81
0.00
0.00
Net Other Financing Charges
-1.53
-359.52%
-0.33
+68.93%
-1.07
+19.26%
-1.33
Changes In Cash
5.11
+232.31%
-3.86
-36.11%
-2.84
-325.41%
1.26
Beginning Cash Position
1.46
-72.57%
5.32
-34.78%
8.16
+18.24%
6.90
End Cash Position
6.57
+350.01%
1.46
-72.57%
5.32
-34.78%
8.16
Free Cash Flow
-2.92
+73.78%
-11.13
+16.12%
-13.27
-70.26%
-7.79
Amortization Of Securities
—
0.00
+100.00%
-0.05
-297.27%
-0.01
Common Stock Issuance
9.61
+63.76%
5.87
-31.66%
8.59
-35.66%
13.35
Issuance Of Capital Stock
9.61
+63.76%
5.87
-31.66%
8.59
-35.66%
13.35
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category